These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34628536)

  • 1. Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosis.
    Mukozu T; Nagai H; Matsui D; Mohri K; Watanabe G; Yoshimine N; Amanuma M; Kobayashi K; Ogino Y; Matsukiyo Y; Matsui T; Daido Y; Wakui N; Shinohara M; Momiyama K; Higai K; Igarashi Y
    Cancer Chemother Pharmacol; 2022 Jan; 89(1):11-20. PubMed ID: 34628536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib
    Kuzuya T; Ishigami M; Ito T; Ishizu Y; Honda T; Ishikawa T; Fujishiro M
    Anticancer Res; 2020 Apr; 40(4):2283-2290. PubMed ID: 32234927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
    Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
    Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of advanced HCC treated with lenvatinib after hepatic arterial infusion chemotherapy combined with radiation therapy treatment for portal vein tumor thrombosis in the main trunk.
    Kosaka Y; Kawaoka T; Aikata H; Suehiro Y; Yamaoka K; Ando Y; Namba M; Takeuchi Y; Fujii Y; Uchikawa S; Kodama K; Oya K; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Imamura M; Baba Y; Awai K; Kimura T; Nagata Y; Chayama K
    Clin J Gastroenterol; 2020 Oct; 13(5):839-843. PubMed ID: 31974811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
    Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi-institutional propensity-matched cohort study.
    Komatsu S; Ueshima K; Kido M; Kuramitsu K; Tsugawa D; Yanagimoto H; Toyama H; Ku Y; Kudo M; Fukumoto T
    J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):303-314. PubMed ID: 36047804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma.
    Narita R; Kotoh K; Yoneda A; Motomura M; Harada M
    Anticancer Res; 2020 Sep; 40(9):5271-5276. PubMed ID: 32878816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Lenvatinib Combined with Anti-PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study.
    Ou X; Wu J; Wu J; Fu Y; Zeng Z; Li S; Li Y; Liu D; Li H; Li B; Zhou J; Zhuang S; Cheng S; Zhang Z; Wang K; Qu S; Yan M
    Cancer Res Treat; 2024 Oct; 56(4):1207-1218. PubMed ID: 38697847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Jeong SW; Jang JY; Shim KY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim KH; Kim JH
    Gut Liver; 2013 Nov; 7(6):696-703. PubMed ID: 24312711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis.
    Ji X; Zhang A; Duan X; Wang Q
    Radiat Oncol; 2024 Oct; 19(1):143. PubMed ID: 39394613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study.
    Ding X; Sun W; Li W; Shen Y; Guo X; Teng Y; Liu X; Zheng L; Li W; Chen J
    Cancer; 2021 Oct; 127(20):3782-3793. PubMed ID: 34237154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
    Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of Vp4 hepatocellular carcinoma with tumor thrombosis extending into the confluence of the splenic/portal vein achieved a good prognosis with emergent hepatectomy and postoperative adjuvant therapy with lenvatinib.
    Kato H; Asano Y; Ito M; Arakawa S; Shimura M; Koike D; Ochi T; Yasuoka H; Kawai T; Higashiguchi T; Tani H; Kunimura Y; Kondo Y; Nagata H; Sato H; Horiguchi A
    World J Surg Oncol; 2022 Sep; 20(1):278. PubMed ID: 36057621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study.
    Tarantino L; Busto G; Nasto A; Fristachi R; Cacace L; Talamo M; Accardo C; Bortone S; Gallo P; Tarantino P; Nasto RA; Di Minno MN; Ambrosino P
    World J Gastroenterol; 2017 Feb; 23(5):906-918. PubMed ID: 28223736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
    Liu PH; Huo TI; Miksad RA
    Semin Liver Dis; 2018 Aug; 38(3):242-251. PubMed ID: 30041276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis.
    Wang K; Guo WX; Chen MS; Mao YL; Sun BC; Shi J; Zhang YJ; Meng Y; Yang YF; Cong WM; Wu MC; Lau WY; Cheng SQ
    Medicine (Baltimore); 2016 Mar; 95(11):e3015. PubMed ID: 26986115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.
    Fu S; Xu Y; Mao Y; He M; Chen Z; Huang S; Li D; Lv Y; Wu J
    Cancer Med; 2024 May; 13(9):e7105. PubMed ID: 38686567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
    Fu Y; Peng W; Zhang W; Yang Z; Hu Z; Pang Y; Hu D; Chen J; Wang J; Zhou Z; Xu L; Chen M; Zhang Y
    J Gastroenterol; 2023 Apr; 58(4):413-424. PubMed ID: 36894804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis.
    Nakazawa T; Hidaka H; Shibuya A; Okuwaki Y; Tanaka Y; Takada J; Minamino T; Watanabe M; Kokubu S; Koizumi W
    BMC Gastroenterol; 2014 May; 14():84. PubMed ID: 24886354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.